Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) EBIT (2016 - 2025)

United Health Products' EBIT history spans 15 years, with the latest figure at -$264723.0 for Q4 2025.

  • Quarterly results put EBIT at -$264723.0 for Q4 2025, up 66.29% from a year ago — trailing twelve months through Dec 2025 was -$2.3 million (down 12.35% YoY), and the annual figure for FY2025 was -$2.3 million, down 12.35%.
  • EBIT for Q4 2025 was -$264723.0 at United Health Products, down from -$233179.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$233179.0 in Q3 2025 to a low of -$26.7 million in Q1 2021.
  • The 5-year median for EBIT is -$546370.5 (2022), against an average of -$2.0 million.
  • The sharpest move saw EBIT plummeted 4181.01% in 2021, then surged 96.43% in 2022.
  • Year by year, EBIT stood at -$1.1 million in 2021, then soared by 48.31% to -$553563.0 in 2022, then grew by 19.31% to -$446657.0 in 2023, then plummeted by 75.84% to -$785398.0 in 2024, then soared by 66.29% to -$264723.0 in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$264723.0, -$233179.0, and -$268356.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.